| Financial Year |
March 31 2023 |
| Monetary Funds |
7,143,974,181.65 |
| Held-for-trading Financial Assets |
23,628,420.42 |
| Notes Receivable |
57,539,630.87 |
| Accounts Receivable |
519,542,394.77 |
| Advances to Suppliers |
522,504,077.25 |
| Other Receivables |
422,477,223.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,693,144,394.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
91,224,850.53 |
| Total Current Assets |
19,711,373,163.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
260,283,337.08 |
| Investment Properties |
-- |
| Fixed Assetes |
16,563,755,006.52 |
| Under-construction Projects |
2,647,431,160.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,229,161,392.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
349,375,090.29 |
| Other Non-Current Assets |
290,109,019.90 |
| Sub-Total of Non-Current Assets |
23,265,237,300.69 |
| Total Assets |
42,976,610,464.42 |
| Short-Term Loans |
4,960,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,235,083,149.83 |
| Accounts Payable |
14,016,643,918.63 |
| Accounts Received In Advance |
1,211,261.61 |
| Employee Compensation Payable |
12,649,246.33 |
| Taxes Payable |
61,910,015.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
893,078,273.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,124,754,740.35 |
| Other Current Liabilities |
323,796,843.82 |
| Sub-Total of Current Liabilities |
28,704,818,973.16 |
| Long-term Loans |
2,967,303,152.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,380,861,835.19 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
45,788,928.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,535,686,494.59 |
| Total Liabilities |
35,240,505,467.75 |
| Paid-In Capital(Or Share Stock) |
2,872,421,386.00 |
| Capital Surplus |
4,541,338,463.55 |
| Surplus Reserve |
1,723,034,456.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,112,362,816.50 |
| Minority Stockholder's Interest |
636,010,813.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,100,094,183.42 |
| Owner's Equity（Stockholder's Equity） |
7,736,104,996.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
42,976,610,464.42 |
